Lista de obras - Anna Grazia Recchia - Dominio Público Uruguay

A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.

artículo científico publicado en 2008

A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.

artículo científico publicado en 2012

A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat.

artículo científico publicado en 2009

A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).

artículo científico publicado en 2016

A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy

artículo científico publicado en 2016

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

artículo científico publicado en 2015

An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma

scientific article published on 18 November 2019

An old drug with a new future: bendamustine in multiple myeloma.

artículo científico publicado en 2013

Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.

artículo científico publicado en 2005

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia

artículo científico publicado en 2015

Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study.

artículo científico publicado en 2017

Bendamustine in multiple myeloma

artículo científico

Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway

artículo científico publicado en 2008

Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia

artículo científico publicado en 2011

Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.

artículo científico publicado en 2012

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review

artículo científico publicado en 2015

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

artículo científico publicado en 2013

Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome

artículo científico publicado en 2003

Diagnostic approaches for identifying acute graft-versus-host disease: what comes next?

artículo científico publicado en 2013

Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib.

artículo científico publicado en 2017

Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia

artículo científico publicado en 2013

E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features

scientific article published on 01 February 2003

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy

artículo científico publicado en 2017

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients

artículo científico publicado en 2015

Emerging biological insights and novel treatment strategies in multiple myeloma

artículo científico

Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes

artículo científico publicado en 2008

Enumeration of interleukin-10-positive B cells from peripheral blood of patients with chronic lymphocytic leukemia

artículo científico publicado en 2014

Epigenetic regulation in myelodysplastic syndromes: implications for therapy

artículo científico publicado en 2011

Erythroid but not cytogenetic response in a case with 5q- syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?

artículo científico publicado en 2013

Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib

artículo científico publicado en 2013

Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques

artículo científico publicado en 2015

High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications

artículo científico publicado en 2014

Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia

artículo científico publicado en 2015

Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.

artículo científico publicado en 2014

Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases

artículo científico publicado en 2014

Ixazomib for the treatment of multiple myeloma.

artículo científico

Janus kinase 2 inhibitors in myeloproliferative disorders

artículo científico publicado en 2010

Lenalidomide for the treatment of mantle cell lymphoma

artículo científico publicado en 2019

Lenalidomide in the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2011

Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients

artículo científico publicado en 2010

Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation

artículo científico publicado en 2016

Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?

artículo científico publicado en 2012

Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.

artículo científico publicado en 2015

More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2010

Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in Chronic lymphocytic leukemia: A comparative study

scientific article published on 02 June 2011

N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity.

artículo científico publicado en 2012

Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells

artículo científico publicado en 2004

Organization and Functioning of an Adverse Drug Reaction Clinic

artículo científico publicado en 1994

Panobinostat for the treatment of acute myelogenous leukemia

artículo científico publicado en 2016

Perspectives in the treatment of multiple myeloma

artículo científico

Pomalidomide in multiple myeloma.

artículo científico publicado en 2016

Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.

artículo científico publicado en 2017

Promising therapies for the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2015

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials

scientific article published on 03 July 2019

Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia

artículo científico publicado en 2014

Rituximab for the treatment of patients with chronic lymphocytic leukemia

artículo científico publicado en 2010

Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patients

artículo científico publicado en 2014

Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia

artículo científico publicado en 2013

Smoldering multiple myeloma: to treat or not to treat.

artículo científico publicado en 2015

Sorafenib for the treatment of multiple myeloma.

artículo científico publicado en 2016

Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment

artículo científico

Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium

artículo científico publicado en 2012

The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.

artículo científico publicado en 2004

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells

artículo científico publicado en 2005

The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes

artículo científico publicado en 2011

The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

artículo científico publicado en 2016

The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia

artículo científico publicado en 2011

The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells

artículo científico publicado en 2003

The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells.

artículo científico publicado en 2005

The role of tandem stem cell transplantation for multiple myeloma patients

artículo científico

Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study

artículo científico publicado en 2013

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

artículo científico publicado en 2016

Venetoclax for the treatment of chronic lymphocytic leukemia.

artículo científico publicado en 2017

Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.

artículo científico publicado en 2004

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome

artículo científico publicado en 2016

microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters

scientific article published on 10 June 2014

Lista de obras de Anna Grazia Recchia

A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.

A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.

A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat.

A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).

A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma

An old drug with a new future: bendamustine in multiple myeloma.

Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia

Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study.

Bendamustine in multiple myeloma

Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway

Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia

Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome

Diagnostic approaches for identifying acute graft-versus-host disease: what comes next?

Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib.

Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia

E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients

Emerging biological insights and novel treatment strategies in multiple myeloma

Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes

Enumeration of interleukin-10-positive B cells from peripheral blood of patients with chronic lymphocytic leukemia

Epigenetic regulation in myelodysplastic syndromes: implications for therapy

Erythroid but not cytogenetic response in a case with 5q- syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?

Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib

Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques

High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications

Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia

Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.

Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases

Ixazomib for the treatment of multiple myeloma.

Janus kinase 2 inhibitors in myeloproliferative disorders

Lenalidomide for the treatment of mantle cell lymphoma

Lenalidomide in the treatment of chronic lymphocytic leukemia

Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients

Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation

Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?

Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.

More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemia

Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in Chronic lymphocytic leukemia: A comparative study

N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity.

Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells

Organization and Functioning of an Adverse Drug Reaction Clinic

Panobinostat for the treatment of acute myelogenous leukemia

Perspectives in the treatment of multiple myeloma

Pomalidomide in multiple myeloma.

Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.

Promising therapies for the treatment of chronic lymphocytic leukemia

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials

Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia

Rituximab for the treatment of patients with chronic lymphocytic leukemia

Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patients

Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia

Smoldering multiple myeloma: to treat or not to treat.

Sorafenib for the treatment of multiple myeloma.

Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment

Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium

The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells

The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes

The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia

The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells

The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells.

The role of tandem stem cell transplantation for multiple myeloma patients

Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

Venetoclax for the treatment of chronic lymphocytic leukemia.

Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome

microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters